Absolute Configuration of Glycerol Derivatives. 5.1 Oxprenolol Enantiomers

Journal of Organic Chemistry

Volumn 43, Issue 19, 1978, Pages 3641-3645

  Nelson, Wendel L ^a   Burke, Terrence R ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXPRENOLOL;

CIRCULAR DICHROISM; DRUG ANALYSIS; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; INFRARED SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; THEORETICAL STUDY;

EID: 0018222104     PISSN: 00223263     EISSN: 15206904     Source Type: Journal    
DOI: 10.1021/jo00413a002     Document Type: Article

References (35)

1. Paper 4: W. L. Nelson, J. E. Wennerstrom, D. C. Dyer, and M. Engel, J. Med. Chem., 20, 880 (1977).
2. For a recent review, see M. E. Connolly, F. Kersting, and C. T. Dollery, Prog. Cardiovasc. Dis., 19, 203 (1976).
3. C. F. George, Prescriber's J., 14, 93 (1974), Drug Ther. Bull., 9, 1(1971)
4. G. Sandler and A. C. Pistevos, Br. Med. J„ 254 (1971).
5. D. Gas and M. Kregar, Ann. Intern. Med., 70, 985 (1970);
6. Granville-Grossman P. Turner, Lancet, 1, 788 (1966);
7. H. J. Grosz, Turner, Lancet, 2, 564 (1972);
8. D. R. Hadden, D. A. Montgomery, R. G. Shanks, and J. A. Weaver, Turner, Lancet, 2, 852 (1968);
9. H. F. Morelli, Ann. Intern. Med., 78, 913 (1973);
10. D. A. L. Owen and C. D. Marsden, Lancet, 2, 1259 (1965);
11. R. B. Weber and O. M. Reinmuth, Neurology, 22, 366 (1972);
12. R. R. Young, J. H. Gowen, and B. T. Shahani, New Eng. J. Med., 293, 950 (1975).
13. A. M. Barrett, and V. A. Cullum, Br. J. Pharmacol., 34 (1968);
14. V. Abead, M. Brogard, and L. Ek, Acta Pharmacol. Toxicol., Suppl. 2, 25, 9 (1967);
15. V. M. Meier, P. R. Hedwall, P. Imhof, and H. Brunner, Arzneimittel Forsch., 12, 190 (1970);
16. K. Kawashima, A. Levy and S. Spector, J. Pharmacol. Exp. Ther., 196, 517 (1976);
17. H. Erhsson, J. Pharmacol., 27, 971 (1975).
18. M. Dukes and L. H. Smith, J. Med. Chem., 14, 326 (1971).
19. J. C. Danilewicz and J. E. G. Kemp, J. Med. Chem., 16, 168 (1973);
20. L. M. Weinstock, O. M. Mulvey, and R. Tull, J. Org. Chem., 41, 3121 (1976); (7) J. A. Edwards, B. Berkoz, G. S. Lewis, O. Halpem, J. H. Fried, A. M. Strosberg, L. M. Miller, S. Urich, F. Lus, and A. P. Roskowski, J. Med. Chem., 17, 200 (1974);
21. W. L. Nelson, J. E. Wennerstrom, and S. R. Sankar, J. Org. Chem., 42, 1006 (1977);
22. W. L. Nelson, and C. E. Wood, Jr., J. Chem. Soc., Chem. Commun., 893 (1973).
23. W. L. Nelson and J. E. Wennerstrom, J. Chem. Soc., Chem. Commun., 921 (1976).
24. E. Baer, Biochem. Prep., 2, 31 (1952).
25. R. S. Cahn, C. K. Ingold, and V. Prelog, Experentia, 12, 81 (1956);
26. R. S. Cahn, C. K. Ingold, and V. Prelog, Angew. Chem., Int. Ed. Engl., 5, 385 (1966).
27. J. Dale, D. Dull, and H. Mosher, J. Org., Chem., 34, 2543 (1969);
28. C. A. Baxter and H. C. Richards, Tetrahedron Lett., 3357 (1972).
29. J. Gal, J. Pharm. Sci., 66, 169 (1977).
30. For examples, see: (a) J. V. Hatton and R. E. Richards, Mol. Phys., 5, 139 (1962);
31. L. A. LaPlanche and M. T. Rogers, J. Am. Chem. Soc., 86, 337 (1964);
32. R. M. Moriarty, J. Org. Chem., 28, 1296 (1963).
33. L. A. Mitscher, P. W. Howison, and T. D. Sokoloski, J. Med. Chem., 16, 98 (1973).
34. W. L. Nelson, M. L. Powell, and J. E. Wennerstrom, J. Org. Chem., in press.
35. D. A. Gartiez and T. Walle, J. Pharm. Sci., 61, 1728 (1972).